デフォルト表紙
市場調査レポート
商品コード
1376204

医薬品ファインケミカルの市場規模、シェア、動向分析レポート:タイプ別、製品別、化学物質別、用途別、地域別、セグメント別予測、2023年~2030年

Pharmaceutical Fine Chemicals Market Size, Share & Trends Analysis Report By Type (Proprietary, Non Proprietary), By Product, By Chemical, By Application, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 122 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
医薬品ファインケミカルの市場規模、シェア、動向分析レポート:タイプ別、製品別、化学物質別、用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年10月25日
発行: Grand View Research
ページ情報: 英文 122 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品ファインケミカル市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、医薬品ファインケミカルの世界市場は2030年までに2,335億米ドルに達する見込みです。

2023年から2030年までのCAGRは7.9%で拡大する見込みです。予防医療に対する需要の高まりが市場成長を牽引する主要因になると予想されます。世界中で高齢化人口が増加しているため、医薬用ファインケミカル(PFC)の利用が増加しています。

心血管は、今後8年間で推定CAGR 8.4%で最も急成長する用途セグメントになると予想されます。心血管疾患の発生は、人間の不健康なライフスタイルのために増加傾向にあります。世界保健機関(WHO)によると、心血管疾患は世界中で死亡の主な原因となっています。同機関はまた、2015年には心血管疾患により約1,770万人が死亡したと述べています。この数字は2015年の総死亡者数の約31%に相当します。

肥満と不健康なライフスタイルは、心血管疾患、神経疾患、腫瘍疾患、感染症、代謝系疾患、糖尿病、呼吸器疾患、消化器疾患、筋骨格系疾患など、さまざまな疾患の発生につながる最も重要な要因の1つです。ジャンクフードを食べたり、不衛生な生活を送ったり、不規則なスケジュールを組んだり、その他多くの不健康な習慣が人間の病気を引き起こします。また、研究によると、女性に比べて男性の方が糖尿病にかかる確率が高いです。これらの要因が相まって、予測期間中の市場成長が促進されると予想されます。

医薬品ファインケミカル市場レポートハイライト

  • 専売は2022年に最大のタイプセグメントとして浮上し、2022年の売上高シェアは81.6%と推定されます。
  • 高分子は2022年に最大のサイズセグメントとなり、今後8年間の推定CAGRは7.8%と見込まれます。
  • 基本構成要素分野は、予測期間中にCAGR 7.5%を記録すると予測されています。基本構成要素は、反応性官能基を有する仮想的な分子断片です。
  • 北米は世界の医薬品ファインケミカル市場を独占し、2022年には37.3%の最大の売上シェアを占めました。北米地域は、製造や消費に関する厳しい法律や規制が存在することが特徴です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品ファインケミカル市場の変数、動向、範囲

  • 市場系統の見通し
  • 普及と成長の見通しマッピング
  • バリューチェーン分析
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の機会と課題
  • 医薬品ファインケミカル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 サプライヤーのポートフォリオ分析

  • サプライヤー一覧
  • Kraljic Matrix
  • 調達のベストプラクティス
  • 交渉戦略

第5章 医薬品ファインケミカル:タイプの推定・動向分析

  • 医薬品ファインケミカル市場:重要なポイント
  • 医薬品ファインケミカル市場:動向と市場シェア分析、2022年および2030年
  • 専売
  • 非専売

第6章 医薬品ファインケミカル:製品の推定・動向分析

  • 医薬品ファインケミカル市場:重要なポイント
  • 医薬品ファインケミカル市場:動向と市場シェア分析、2022年および2030年
  • 基本構成要素
  • 先進的中間体
  • 有効成分

第7章 医薬品ファインケミカル:化学物質の推定・動向分析

  • 医薬品ファインケミカル市場:重要なポイント
  • 医薬品ファインケミカル市場:動向と市場シェア分析、2022年および2030年
  • 低分子
  • 高分子

第8章 医薬品ファインケミカル:用途の推定・動向分析

  • 医薬品ファインケミカル市場:重要なポイント
  • 医薬品ファインケミカル市場:動向と市場シェア分析、2022年および2030年
  • 心血管
  • 神経系
  • 腫瘍学
  • 感染症
  • 代謝システム
  • 糖尿病
  • 呼吸器系
  • 胃腸
  • 筋骨格系
  • その他

第9章 医薬品ファインケミカル市場:地域の推定・動向分析

  • 地域の見通し
  • 地域別の医薬品ファインケミカル市場:重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
  • 中南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Denisco
    • Albemarle Corporation
    • Kenko Corporation
    • GRACE
    • CHEMADA
    • JMP Statistical Discovery LLC.
    • Pfizer Inc.
    • GSK plc
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 5 North America pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America pharmaceutical fine chemicals market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 10 U.S. pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 14 Canada pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 15 Mexico pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 18 Mexico pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 22 Europe pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe pharmaceutical fine chemicals market, by region, 2018 - 2030 (USD Million)
  • Table 24 Germany pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 27 Germany pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 31 UK pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 32 France pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 33 France pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 34 France pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 35 France pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 36 Italy pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 39 Italy pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 40 Spain pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 43 Spain pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pharmaceutical fine chemicals market, by region, 2018 - 2030 (USD Million)
  • Table 49 China pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 50 China pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 51 China pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 52 China pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 54 Japan pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 56 Japan pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 57 India pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 58 India pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 59 India pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 60 India pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 62 South Korea pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 63 South Korea pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 64 South Korea pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 65 Central & South America pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 66 Central & South America pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 67 Central & South America pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 68 Central & South America pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 69 Central & South America pharmaceutical fine chemicals market, by region, 2018 - 2030 (USD Million)
  • Table 70 Brazil pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 71 Brazil pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 72 Brazil pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 73 Brazil pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 75 Argentina pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 76 Argentina pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 77 Argentina pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 79 Middle East and Africa pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East and Africa pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa pharmaceutical fine chemicals market, by region, 2018 - 2030 (USD Million)
  • Table 83 South Africa pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 86 South Africa pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pharmaceutical fine chemicals market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pharmaceutical fine chemicals market, by product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia pharmaceutical fine chemicals market, by chemical, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia pharmaceutical fine chemicals market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharmaceutical fine chemicals: Market outlook
  • Fig. 9 Pharmaceutical fine chemicals: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Pharmaceutical fine chemicals market driver impact
  • Fig. 15 Pharmaceutical fine chemicals market restraint impact
  • Fig. 16 Pharmaceutical fine chemicals market strategic initiatives analysis
  • Fig. 17 Pharmaceutical fine chemicals market: Type movement analysis
  • Fig. 18 Pharmaceutical fine chemicals market: Type outlook and key takeaways
  • Fig. 19 Proprietary market estimates and forecasts, 2018 - 2030
  • Fig. 20 Non-proprietary market estimates and forecasts, 2018 - 2030
  • Fig. 21 Pharmaceutical fine chemicals market: Chemical movement analysis
  • Fig. 22 Pharmaceutical fine chemicals market: Chemical outlook and key takeaways
  • Fig. 23 Small molecules market estimates and forecasts, 2018 - 2030
  • Fig. 24 Big molecules market estimates and forecasts, 2018 - 2030
  • Fig. 25 Pharmaceutical fine chemicals market: Product movement analysis
  • Fig. 26 Pharmaceutical fine chemicals market: Product outlook and key takeaways
  • Fig. 27 Basic building blocks market estimates and forecasts, 2018 - 2030
  • Fig. 28 Advanced intermediates market estimates and forecasts, 2018 - 2030
  • Fig. 29 Active ingredients market estimates and forecasts, 2018 - 2030
  • Fig. 30 Pharmaceutical fine chemicals market: Application movement analysis
  • Fig. 31 Pharmaceutical fine chemicals market: Application outlook and key takeaways
  • Fig. 32 Cardiovascular market estimates and forecasts, 2018 - 2030
  • Fig. 33 Neurological market estimates and forecasts, 2018 - 2030
  • Fig. 34 Oncological market estimates and forecasts, 2018 - 2030
  • Fig. 35 Infectious diseases market estimates and forecasts, 2018 - 2030
  • Fig. 36 Metabolic system market estimates and forecasts, 2018 - 2030
  • Fig. 37 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 38 Respiratory market estimates and forecasts, 2018 - 2030
  • Fig. 39 Gastrointestinal market estimates and forecasts, 2018 - 2030
  • Fig. 40 Musculoskeletal market estimates and forecasts, 2018 - 2030
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030
  • Fig. 42 Global pharmaceutical fine chemicals market: Regional movement analysis
  • Fig. 43 Global pharmaceutical fine chemicals market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 51 France market estimates and forecasts, 2018 - 2030
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Central & South America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-978-4

Pharmaceutical Fine Chemicals Market Growth & Trends:

The global pharmaceutical fine chemicals market is expected to reach USD 233.5 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 7.9% from 2023 to 2030. Increasing demand for preventive healthcare is expected to be a major factor in driving the market growth. The utilization of pharmaceutical fine chemicals (PFCs) has increased on account of the increasing aging population across the globe.

Cardiovascular is anticipated to the fastest-growing application segment over the next eight years growing at an estimated CAGR of 8.4%. The occurrence of cardiovascular disease is on the rise owing to the unhealthy lifestyle of human beings. According to the World Health Organization (WHO), cardiovascular diseases are considered to be the prime cause of fatalities across the globe. The organization also states that cardiovascular diseases caused the death of approximately 17.7 million people in the year 2015. This number approximately represented 31% of the total deaths in the year 2015.

Obesity and an unhealthy lifestyle are some of the most important factors which lead to the occurrence of various diseases such as cardiovascular, neurological, oncological, infectious diseases, metabolic system, diabetes, respiratory, gastrointestinal, and musculoskeletal disorders. Eating junk food, leading unhygienic lifestyle, irregular timetable and many other unhealthy habits lead to diseases amongst human beings. Studies also show that males have more chance of contracting diabetes as compared to females. All these factors combined are thus anticipated to propel the market growth over the forecast period.

Pharmaceutical Fine Chemicals Market Report Highlights:

  • Proprietary emerged as the largest type segment in 2022 and is estimated to generate revenue share of 81.6% in 2022
  • Big molecules were the largest size segment in 2022 and are expected to grow at an estimated CAGR of 7.8% over the next eight years
  • The basic building blocks segment is expected to register a CAGR of 7.5% over the forecast period. Basic building blocks is a virtual molecular fragment possessing a reactive functional group
  • North America dominated the global pharmaceutical fine chemicals market and accounted for the largest revenue share of 37.3% in 2022. North America region is characterized by the presence of strict laws and regulations about manufacturing as well as consumption.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Chemical
    • 1.1.4. Application
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Chemical outlook
    • 2.2.4. Application outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Fine Chemicals Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Industry opportunities & challenges
  • 3.6. Pharmaceutical Fine Chemicals Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Technological landscape
      • 3.6.2.3. Economic landscape
      • 3.6.2.4. Social landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Supplier Portfolio Analysis

  • 4.1. List of Suppliers
  • 4.2. Kraljic Matrix
  • 4.3. Sourcing Best Practices
  • 4.4. Negotiation Strategies

Chapter 5. Pharmaceutical Fine Chemicals: Type Estimates & Trend Analysis

  • 5.1. Pharmaceutical Fine Chemicals Market: Key Takeaways
  • 5.2. Pharmaceutical Fine Chemicals Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Proprietary
    • 5.3.1. Proprietary market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Non-Proprietary
    • 5.4.1. Non Proprietary market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Fine Chemicals: Product Estimates & Trend Analysis

  • 6.1. Pharmaceutical Fine Chemicals Market: Key Takeaways
  • 6.2. Pharmaceutical Fine Chemicals Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Basic Building Blocks
    • 6.3.1. Basic building blocks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Advanced Intermediates
    • 6.4.1. Advanced intermediates market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Active Ingredients
    • 6.5.1. Active ingredients market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Fine Chemicals: Chemical Estimates & Trend Analysis

  • 7.1. Pharmaceutical Fine Chemicals Market: Key Takeaways
  • 7.2. Pharmaceutical Fine Chemicals Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Small Molecules
    • 7.3.1. Small molecules market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Big Molecules
    • 7.4.1. Big molecules market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Fine Chemicals: Application Estimates & Trend Analysis

  • 8.1. Pharmaceutical Fine Chemicals Market: Key Takeaways
  • 8.2. Pharmaceutical Fine Chemicals Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Cardiovascular
    • 8.3.1. Cardiovascular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Neurological
    • 8.4.1. Neurological market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Oncological
    • 8.5.1. Oncological market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Infectious Diseases
    • 8.6.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Metabolic System
    • 8.7.1. Metabolic system market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8. Diabetes
    • 8.8.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9. Respiratory
    • 8.9.1. Respiratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.10. Gastrointestinal
    • 8.10.1. Gastrointestinal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.11. Musculoskeletal
    • 8.11.1. Musculoskeletal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.12. Others
    • 8.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Pharmaceutical Fine Chemicals Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. Pharmaceutical Fine Chemicals Market by Region: Key Takeaway
  • 9.3. North America
    • 9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.3. France
      • 9.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.2. China
      • 9.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.3. India
      • 9.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.4. South Korea
      • 9.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6. Central & South America
    • 9.6.1. Brazil
      • 9.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. Saudi Arabia
      • 9.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Denisco
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. Albemarle Corporation
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Kenko Corporation
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. GRACE
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. CHEMADA
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. JMP Statistical Discovery LLC.
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Pfizer Inc.
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. GSK plc
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives